IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.215
EU - Europa 11.720
AS - Asia 10.268
SA - Sud America 1.619
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 6
Totale 38.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.940
SG - Singapore 3.877
RU - Federazione Russa 3.220
CN - Cina 2.914
UA - Ucraina 1.876
IE - Irlanda 1.541
TR - Turchia 1.429
BR - Brasile 1.326
SE - Svezia 993
GB - Regno Unito 964
VN - Vietnam 939
IT - Italia 918
DE - Germania 760
FR - Francia 691
FI - Finlandia 428
IN - India 405
BD - Bangladesh 170
CA - Canada 127
AR - Argentina 124
HK - Hong Kong 103
MX - Messico 88
PL - Polonia 78
IQ - Iraq 65
ZA - Sudafrica 61
EC - Ecuador 57
JP - Giappone 49
ID - Indonesia 44
CZ - Repubblica Ceca 40
ES - Italia 40
AT - Austria 39
KR - Corea 39
NL - Olanda 35
PK - Pakistan 35
MA - Marocco 31
EU - Europa 26
VE - Venezuela 24
CO - Colombia 22
IL - Israele 21
UZ - Uzbekistan 21
PY - Paraguay 19
SA - Arabia Saudita 18
CL - Cile 17
AE - Emirati Arabi Uniti 16
BE - Belgio 15
IR - Iran 14
LT - Lituania 14
PH - Filippine 14
AZ - Azerbaigian 13
UY - Uruguay 13
DZ - Algeria 11
EG - Egitto 11
TN - Tunisia 11
HN - Honduras 10
JO - Giordania 10
PE - Perù 10
RO - Romania 10
CR - Costa Rica 9
JM - Giamaica 9
KZ - Kazakistan 9
OM - Oman 9
AL - Albania 8
KE - Kenya 8
LB - Libano 8
MY - Malesia 8
BG - Bulgaria 7
ET - Etiopia 7
NI - Nicaragua 7
BO - Bolivia 6
CH - Svizzera 6
TW - Taiwan 6
DO - Repubblica Dominicana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
BZ - Belize 4
DK - Danimarca 4
GR - Grecia 4
KG - Kirghizistan 4
NG - Nigeria 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
NP - Nepal 3
PS - Palestinian Territory 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
Totale 37.989
Salva come PNG Salva come JPEG
Città #
Singapore 2.945
Jacksonville 2.154
San Jose 1.557
Dublin 1.532
Chandler 1.452
Ashburn 888
Princeton 744
Izmir 732
Dallas 666
Southend 656
Beijing 616
Nanjing 603
Wilmington 383
Santa Clara 363
Los Angeles 362
Cambridge 340
Ho Chi Minh City 326
Dearborn 298
Altamura 295
Nanchang 224
Council Bluffs 210
Tongling 210
New York 208
Hanoi 203
Buffalo 188
Moscow 181
The Dalles 167
Ann Arbor 164
Munich 140
São Paulo 136
Chieti 131
Boardman 113
Hebei 103
Shenyang 103
Woodbridge 101
Hong Kong 97
Tianjin 91
Kunming 88
Washington 70
Jiaxing 69
Grevenbroich 67
Helsinki 60
Orem 58
Norwalk 56
Changsha 54
Redondo Beach 54
Warsaw 54
Haiphong 53
Brooklyn 52
Montreal 51
Tokyo 44
Da Nang 41
Johannesburg 41
Chennai 39
Denver 39
Houston 39
Hangzhou 38
Seoul 37
Atlanta 35
Frankfurt am Main 34
Rome 34
Augusta 33
Turku 33
Seattle 32
Stockholm 32
Toronto 32
Orange 31
Poplar 31
Rio de Janeiro 30
Baghdad 29
Brno 28
Jinan 28
Changchun 27
Lanzhou 27
London 27
Mexico City 27
San Francisco 27
Belo Horizonte 26
St Louis 26
Chicago 25
Hefei 25
San Mateo 25
Boston 24
Guayaquil 23
Pescara 23
Shanghai 23
Biên Hòa 22
Brasília 22
Mumbai 22
Ningbo 22
Manchester 21
Phoenix 21
Curitiba 20
Milan 20
Falls Church 19
Leawood 18
Nuremberg 18
Tashkent 18
Hải Dương 17
Quito 17
Totale 21.860
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 830
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 821
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 809
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 203
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 193
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 189
Pentraxin 3 and platelet activation in obese patients after gastric banding 180
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 170
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 166
A comparison of five maintenance therapies for reflux esophagitis 164
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 163
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 162
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 162
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 158
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 158
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 158
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 155
Determinants of platelet activation in hypertensives with microalbuminuria. 154
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 153
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 149
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 147
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 145
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 145
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 145
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 144
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 143
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 143
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 143
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 142
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 141
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 141
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 141
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 141
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 141
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 140
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 140
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Platelets and Diabetes 138
[The "problem obesity": viewpoint of the internist] 138
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 137
Increased soluble CD40L levels in cystic fibrosis 137
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 137
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 136
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 135
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 135
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 135
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 134
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 133
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 133
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 133
Leptin increase is associated with markers of the hemostatic system in obese healthy women 132
Insulin resistance as a determinant of platelet activation in obese women. 132
[The "problem obesity": viewpoint of the internist]. 132
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 132
Coagulation and infective endocarditis: sooner or later 132
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 131
Platelet activation in obesity and metabolic syndrome. 131
[Considerations on platelet aggregation inhibition in patients treated with acetylsalicylic acid]. 131
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 131
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 131
Aspirin, platelets, and cancer: The point of view of the internist. 131
Platelets and diabetes mellitus 131
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 130
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 129
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 128
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 128
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 128
Association between serum leptin levels and 24-hour blood pressure in obese women. 128
Homocysteine modulates the CD40/CD40L system 127
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 127
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 127
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 126
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 126
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 126
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 125
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 125
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 125
Diabetes mellitus and thrombosis 125
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 125
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 124
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 124
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 124
The relationship between clinical events and JAK2V617F mutation status in a cohort of 75 patients with essential thrombocythemia 124
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 124
Determinants of platelet activation in hypertensives with microalbuminuria. 123
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 123
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 123
Soluble RAGE in type 2 diabetes: association with oxidative stress. 122
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 121
Association between PAI-1 and Oxidative Stress in Android Obesity 121
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 121
Antipsychotic prescription and mortality in hospitalized older persons 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 120
Soluble forms of RAGE in internal medicine. 120
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 119
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 119
Totale 15.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20255.400 463 1.089 862 67 77 134 82 223 519 207 566 1.111
2025/202613.478 911 482 1.396 1.875 951 642 1.613 732 3.178 999 542 157
Totale 39.116